Publications, Pharmaceutical

Evaluating the Particle Distribution for Dry Powder Inhalers

Fluidization and disaggregation processes during dry powder inhaler use influence the aerodynamic particle size distribution, permeation, and dissolution of the active pharmaceutical ingredient(s).

This paper describes work to develop an effective test set-up to elucidate these effects by combining laser diffraction particle size distribution measurement (Spraytec) with automated imaging, via Unidose. Unidose is an apparatus developed by Nanopharm, an Aptar company. By capturing the whole impactor sized mass it enables the application of morphologically directed Raman spectroscopy to particles in the size range associated with respiratory drug delivery. Set-ups were tested with different throat models and with different commercially available dry powders inhalers. Particle size distribution data were successfully measured by laser diffraction using the developed test set-ups, and the results were compared with those generated by imaging.

Download Publication
15 Jun 2020

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More

This Might Also Be of Interest

13 Mar 2024

In Silico Modelling for Orally Inhaled Drug Development (OINDP)

Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
7 Mar 2024

Sustainable Propellants and Bioequivalence Innovation in OINDPs

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
13 Dec 2023

Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 4 19
Back To Top